As stated in many of our previous newsletters and white papers, continuous processing in the pharmaceutical industry is clearly gaining momentum and is well positioned for even further advancement in the future. This blog, recently posted by Dave Di Prospero of CRB USA, and approved by Dave for further reference in this newsletter, is a prime example of the advances of the current FDA approved drugs manufactured by continuous processes. Most importantly, it addresses the life difference these drugs have made to many who are afflicted with the diseases referenced. For these reasons, Coperion K-Tron is especially proud to be a supplier of the highly accurate loss in weight feeders for the delivery of excipients and API’s to every one of the systems referenced, including direct compression, and wet and dry granulations. This informative blog is just one small example of the achievements by the companies involved in this and future continuous manufacturing development. These achievements are not only admirable from a design and engineering perspective, but also from a humanitarian perspective in view of the influential drugs these continuous lines will help bring to market.
Sign up for the Coperion newsletter to receive the latest updates
Continuous OSD Manufacturing - From the perspective of the Patient Impact
Continuous processing in the pharmaceutical industry is clearly gaining momentum and is well positioned for even further advancement in the future. This article by Dave Di Prospero of CRB USA is a prime example of the advances of the current FDA approved drugs manufactured by continuous processes.